Literature DB >> 9755846

No effect of probenecid on the renal excretion mechanism of a new carbapenem, DA-1131, in dogs.

S H Kim1, W B Kim, M G Lee.   

Abstract

The effect of probenecid, an anion transport inhibitor, on the renal excretion mechanism of a new anionic carbapenem, DA-1131, was investigated after 1-min intravenous infusion of DA-1131, 10 mg/kg, with or without probenecid, 50 mg/kg, to dogs. The renal clearance (CL(R)) of DA-1131 in dogs without probenecid (3.18+/-0.247 ml/min/kg) was considerably smaller than the reported creatinine clearance (CL(CR)) in dogs, 6.13 ml/min/kg, indicating that renal tubular reabsorption of the drug was observed in dogs. However, the CLR of DA-1131 was not significantly different (3.18+/-0.247 versus 3.29+/-0.698 ml/min/kg) by treatment with probenecid indicating that the tubular reabsorption of DA-1131 was not inhibited by probenecid.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9755846

Source DB:  PubMed          Journal:  Res Commun Mol Pathol Pharmacol        ISSN: 1078-0297


  3 in total

Review 1.  Comparative pharmacokinetics of the carbapenems: clinical implications.

Authors:  J W Mouton; D J Touzw; A M Horrevorts; A A Vinks
Journal:  Clin Pharmacokinet       Date:  2000-09       Impact factor: 6.447

2.  Effects of cilastatin on the pharmacokinetics of a new carbapenem, DA-1131, in rats, rabbits, and dogs.

Authors:  S H Kim; J W Kwon; W B Kim; M G Lee
Journal:  Antimicrob Agents Chemother       Date:  1999-10       Impact factor: 5.191

3.  Stability of new carbapenem DA-1131 to renal dipeptidase (dehydropeptidase I).

Authors:  Sung Wook Park; Jeoung Soon We; Gye Won Kim; Seong Hak Choi; Haeng Soon Park
Journal:  Antimicrob Agents Chemother       Date:  2002-02       Impact factor: 5.191

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.